Get access

Screening for Chlamydia infection in a sexually transmitted infection clinic: a missed opportunity?

Authors

  • Ana Filipa Pedrosa MD,

    Corresponding author
    1. Department of Dermatology and Venereology, Centro Hospitalar São João EPE, Porto, Portugal
    • Correspondence

      Ana Filipa Pedrosa, md

      Department of Dermatology and Venereology

      Centro Hospitalar São João EPE Porto

      Alameda Professor Hernani Monteiro

      Porto 4200-319

      Portugal

      E-mail: anabastospedrosa@gmail.com

    Search for more papers by this author
  • Filomena Azevedo MD,

    1. Department of Dermatology and Venereology, Centro Hospitalar São João EPE, Porto, Portugal
    Search for more papers by this author
  • Carmen Lisboa MD, PhD

    1. Department of Dermatology and Venereology, Centro Hospitalar São João EPE, Porto, Portugal
    2. Department of Microbiology, Faculty of Medicine, University of Porto, Porto, Portugal
    Search for more papers by this author

  • Funding: None.
  • Conflicts of interest: None.

Abstract

Objectives

Chlamydia trachomatis (CT) infection is the most common sexually transmitted infection (STI) reported in Europe. We aim to evaluate the overall prevalence of CT infection and the rate of asymptomatic infection in an STI clinic over a 5-year period. We will also discuss screening strategies with reference to attendees diagnosed with an STI and their sexual partners, and attendees with a non-infectious genital dermatosis.

Methods

Clinical and laboratory data for all attendees at a university hospital STI clinic over a 5-year period were reviewed. Diagnosis of CT infection was made upon polymerase chain reaction (PCR) performed in first-void urine.

Results

The overall prevalence of CT infection was 4.0% (53/1310); the rate of asymptomatic infection was 84.9% (45/53). The prevalence of CT infection among attendees with an STI diagnosis and their sexual partners was 5.2% (50/963), whereas that among attendees with a non-infectious genital dermatosis was 0.9% (3/347; < 0.001). Infected attendees were younger than attendees without CT infection (median age: 31 years vs. 40 years; < 0.001). In 39.5% (17/43) of CT-infected attendees, it was possible to notify a sexual partner; CT infection was subsequently diagnosed in 58.8% (10/17) of partners.

Conclusions

Asymptomatic CT infection had a representative frequency, which was more pronounced among young attendees with an STI diagnosis and their sexual partners, to whom screening should be offered. Issues of age limits for screening and whether screening should be directed to males in non-STI clinic settings should be carefully assessed.

Ancillary